Overview

DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
BACKGROUND: Malar melasma has a chronic and recurrent character that may be related with epigenetic changes.
Phase:
Early Phase 1
Details
Lead Sponsor:
Universidad Autonoma de San Luis Potosí
Treatments:
Niacin
Niacinamide
Nicotinic Acids
Sunscreening Agents
Tretinoin